A multicenter real-life study of the efficacy of an alpha-blocker with or without anticholinergic agent (imidafenacin) treatment in patients with lower urinary tract symptoms/benign prostatic hyperplasia and storage symptoms-Reference-Cited by-同舟云学术

A multicenter real-life study of the efficacy of an alpha-blocker with or without anticholinergic agent (imidafenacin) treatment in patients with lower urinary tract symptoms/benign prostatic hyperplasia and storage symptoms

Published:2017-05 Issue:5 Volume:71 Page:e12938
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Cho Seok¹^ORCID,Kwon Soon-Sun²,Lee Kwang Woo³,Yoo Tag Keun⁴,Shin Dong Gil⁵,Kim Soo Woong⁶,Bae Jae Hyun⁷,Choi Hoon⁷^ORCID,Kim Young Ho³

Affiliation:

1. The Department of Urology; Ilsanpaik Hospital; Inje University College of Medicine; Goyang Korea

2. The Department of Mathematics; College of Natural Sciences; Ajou University; Suwon Korea

3. The Department of Urology; Soonchunhyang University Bucheon Hospital; Soonchunhyang University College of Medicine; Bucheon Korea

4. The Department of Urology; Ulji University Nowon Hospital; Ulji University College of Medicine; Daejeon Korea

5. The Department of Urology; Busan University Hospital; Busan University College of Medicine; Busan Korea

6. The Department of Urology; Seoul University Hospital; Seoul University College of Medicine; Seoul Korea

7. The Department of Urology; Korea University Ansan Hospital; Korea University College of Medicine; Ansan Korea

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ijcp.12938/fullpdf

Reference30 articles.

1. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction;Gratzke;Eur Urol,2015

2. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study;Irwin;Eur Urol,2006

3. Epidemiology of lower urinary tract symptoms: emphasis on the status in Korea;Lee;Korean J Urol,2014

4. Defining the role of overactive bladder treatments in men with lower urinary tract symptoms;Lemack;Nat Clin Pract Urol,2007

5. Persistence or recurrence of symptoms after transurethral resection of the prostate: a urodynamic assessment;Seaman;J Urol,1994

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update;Expert Opinion on Emerging Drugs;2024-06-14

2. Novel pharmacotherapeutic avenues for bladder storage dysfunction in men;Expert Opinion on Pharmacotherapy;2024-03-23

3. Comparison of add-on medications for persistent storage symptoms after α-blocker treatment in BPH patients – a network meta-analysis;BMC Urology;2023-10-03

4. Comparison of add-on medications for persistent storage symptoms after α-blockers in BPH patients – a network meta-analysis;2023-04-28

5. Comparative Efficacy of Different Drugs for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: A Bayesian Network Meta-Analysis;Frontiers in Pharmacology;2022-03-07